Fresh Tracks Therapeutics Inc (FRTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access FRTX Annual Balance Sheets →
Balance sheet data covering Fresh Tracks Therapeutics Inc–Dec 31 2022 offers a view into how Dec 31 2023's financial position has changed alongside business activity.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2023)
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent10.87
Cash & Short-term Investments10.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.68
Total Current Assets11.55
Equipment/Property/Plant Net0.03
Other Assets, Noncurrent0.00
Operating Lease Right Of Use Asset-
Total Assets11.59
Liabilities
Accounts Payable, Current AC0.41
Accrued Liabilities, Current AC1.25
Other Liabilities, Current0.00
Total Current Liabilities1.66
Total Long-term Debt0.00
Operating Lease Liability Current-
Total Liabilities1.66
Stockholders' Equity
Common Stock Value0.06
Additional Paid In Capital Common Stock182.03
Retained Earnings / Accumulated Deficit-172.16
Other Equity0.00
Common Stockholder's Equity9.93
Total Stockholder's Equity9.93
Liabilities & Stockholder's Equity11.59
4 historic quarters locked

Sign in to unlock the full Fresh Tracks Therapeutics Inc balance sheet history.

About Fresh Tracks Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-24-011460

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.